Drug class
Vascular-targeted photosensitiser; photodynamic antineoplastic agent
Mechanism of action
After local activation with near-infrared laser light, the photosensitiser generates reactive oxygen species within tumour-associated vasculature. This causes local vascular injury, reduced perfusion and tumour necrosis.
General use cases
- Vascular-targeted photodynamic therapy studied for focal treatment of localised prostate cancer; product availability and authorised use are jurisdiction-specific.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
